ES514263A0 - Un procedimiento para la preparacion de derivados de espiroti-azolidinil-piperazina. - Google Patents
Un procedimiento para la preparacion de derivados de espiroti-azolidinil-piperazina.Info
- Publication number
- ES514263A0 ES514263A0 ES514263A ES514263A ES514263A0 ES 514263 A0 ES514263 A0 ES 514263A0 ES 514263 A ES514263 A ES 514263A ES 514263 A ES514263 A ES 514263A ES 514263 A0 ES514263 A0 ES 514263A0
- Authority
- ES
- Spain
- Prior art keywords
- spiroti
- azolidinyl
- procedure
- preparation
- piperazine derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- C07D213/85—Nitriles in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/289,351 US4456756A (en) | 1981-08-03 | 1981-08-03 | Spirothiazolidinyl piperazine derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
ES514263A0 true ES514263A0 (es) | 1984-01-01 |
ES8401763A1 ES8401763A1 (es) | 1984-01-01 |
Family
ID=23111156
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES514263A Expired ES8401763A1 (es) | 1981-08-03 | 1982-07-23 | Un procedimiento para la preparacion de derivados de espiroti-azolidinil-piperazina. |
ES526149A Granted ES526149A0 (es) | 1981-08-03 | 1983-09-30 | Un procedimiento para la preparacion de derivados de espirotiazolidinil-piperazina |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES526149A Granted ES526149A0 (es) | 1981-08-03 | 1983-09-30 | Un procedimiento para la preparacion de derivados de espirotiazolidinil-piperazina |
Country Status (28)
Country | Link |
---|---|
US (1) | US4456756A (es) |
JP (1) | JPS5838277A (es) |
KR (1) | KR880001737B1 (es) |
AT (1) | AT380477B (es) |
AU (1) | AU555870B2 (es) |
BE (1) | BE894021A (es) |
CA (1) | CA1208642A (es) |
CH (1) | CH655503B (es) |
DE (1) | DE3228992A1 (es) |
DK (1) | DK156219C (es) |
ES (2) | ES8401763A1 (es) |
FI (1) | FI76794C (es) |
FR (1) | FR2510571B1 (es) |
GB (1) | GB2105714B (es) |
GR (1) | GR76171B (es) |
HU (1) | HU191505B (es) |
IE (1) | IE53613B1 (es) |
IL (1) | IL66433A (es) |
IT (1) | IT1149026B (es) |
LU (1) | LU84315A1 (es) |
NL (1) | NL8203035A (es) |
NZ (1) | NZ201158A (es) |
OA (1) | OA07171A (es) |
PH (1) | PH18688A (es) |
PT (1) | PT75365B (es) |
SE (1) | SE453503B (es) |
YU (1) | YU44073B (es) |
ZA (1) | ZA825481B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61162278A (ja) * | 1985-01-09 | 1986-07-22 | Nippon Yakin Kogyo Co Ltd | 冷却手段を具えたロ−ラ−電極を含む自走式シ−ム溶接機 |
US4619930A (en) * | 1985-01-16 | 1986-10-28 | Bristol-Myers Company | Antipsychotic cyclic imide derivatives of 2-(4-butylpiperazin-1-yl)pyridines, compositions and use |
US4677104A (en) * | 1985-05-06 | 1987-06-30 | Bristol-Myers Company | Antipsychotic fused-ring pyridinylpiperazine derivatives |
US4784998A (en) * | 1987-04-06 | 1988-11-15 | Bristol-Myers Company | 1,3,4-oxadiazole pyschotropic compounds |
ATE81123T1 (de) * | 1987-11-20 | 1992-10-15 | Hoechst Roussel Pharma | 3-(4(1-substituierte-4-piperazinyl)butyl>-4thiazolidinone, verfahren zu deren herstellung und ihre anwendung als arzneimittel. |
US5801186A (en) * | 1987-11-20 | 1998-09-01 | Hoechst Marion Roussel, Inc. | 3- 4-(1-substituted-4-piperazinyl)butyl!-4-thiazolidinone and related compounds |
JPH0270878U (es) * | 1988-11-21 | 1990-05-30 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL265085A (es) * | 1960-05-24 | |||
US3106552A (en) * | 1960-07-19 | 1963-10-08 | Geschickter Fund Med Res | Nu-substituted azaspiranes and azaspirane-diones and processes for their preparation |
US3200118A (en) * | 1961-10-31 | 1965-08-10 | Geschickter Fund Med Res | Spirocyclic hydrazine imides |
US3432499A (en) * | 1965-04-02 | 1969-03-11 | Geschickter Fund Med Res | Trifluoromethylazaspiranes and azaspirane diones |
US3398151A (en) * | 1966-02-01 | 1968-08-20 | Mead Johnson & Co | Azaspirodecanediones and azaspiroundecanediones |
DE1695410A1 (de) * | 1967-04-20 | 1971-04-08 | Merck Patent Gmbh | Verfahren zur Herstellung von 1-(Thiazolyl-5-alkyl)-4-(pyridyl-2)-piperazinen |
BE759371A (fr) * | 1969-11-24 | 1971-05-24 | Bristol Myers Co | Azaspirodecanediones heterocycliques et procedes pour leur preparation |
US3976776A (en) * | 1972-12-06 | 1976-08-24 | Mead Johnson & Company | Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones |
EP0002978B1 (fr) * | 1977-12-29 | 1982-10-06 | Synthelabo | Dérivés de thiazolidinedione-2,4, leur préparation et leur application en thérapeutique |
AU521110B2 (en) * | 1978-06-20 | 1982-03-18 | Synthelabo | Phenylpiperazine derivatives |
US4367335A (en) * | 1981-08-03 | 1983-01-04 | Mead Johnson & Company | Thiazolidinylalkylene piperazine derivatives |
-
1981
- 1981-08-03 US US06/289,351 patent/US4456756A/en not_active Expired - Fee Related
-
1982
- 1982-07-05 NZ NZ201158A patent/NZ201158A/en unknown
- 1982-07-13 AU AU85973/82A patent/AU555870B2/en not_active Ceased
- 1982-07-13 GR GR68740A patent/GR76171B/el unknown
- 1982-07-20 YU YU1585/82A patent/YU44073B/xx unknown
- 1982-07-23 ES ES514263A patent/ES8401763A1/es not_active Expired
- 1982-07-28 FR FR8213176A patent/FR2510571B1/fr not_active Expired
- 1982-07-28 IT IT48901/82A patent/IT1149026B/it active
- 1982-07-29 NL NL8203035A patent/NL8203035A/nl not_active Application Discontinuation
- 1982-07-29 ZA ZA825481A patent/ZA825481B/xx unknown
- 1982-07-30 CA CA000408451A patent/CA1208642A/en not_active Expired
- 1982-07-30 FI FI822666A patent/FI76794C/fi not_active IP Right Cessation
- 1982-07-30 IE IE1851/82A patent/IE53613B1/en unknown
- 1982-07-30 DK DK343782A patent/DK156219C/da not_active IP Right Cessation
- 1982-07-30 PH PH27655A patent/PH18688A/en unknown
- 1982-08-01 IL IL66433A patent/IL66433A/xx unknown
- 1982-08-02 CH CH466082A patent/CH655503B/de unknown
- 1982-08-02 SE SE8204549A patent/SE453503B/sv not_active IP Right Cessation
- 1982-08-02 HU HU822483A patent/HU191505B/hu not_active IP Right Cessation
- 1982-08-02 PT PT75365A patent/PT75365B/pt not_active IP Right Cessation
- 1982-08-02 GB GB08222210A patent/GB2105714B/en not_active Expired
- 1982-08-03 KR KR8203481A patent/KR880001737B1/ko active
- 1982-08-03 DE DE19823228992 patent/DE3228992A1/de not_active Withdrawn
- 1982-08-03 OA OA57764A patent/OA07171A/xx unknown
- 1982-08-03 JP JP57134807A patent/JPS5838277A/ja active Granted
- 1982-08-03 AT AT0299382A patent/AT380477B/de active
- 1982-08-03 LU LU84315A patent/LU84315A1/fr unknown
- 1982-08-03 BE BE0/208747A patent/BE894021A/fr not_active IP Right Cessation
-
1983
- 1983-09-30 ES ES526149A patent/ES526149A0/es active Granted
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES517542A0 (es) | Un procedimiento para la preparacion de derivados de 3-hidroxi-ml-236-b. | |
ES518225A0 (es) | Un procedimiento para la preparacion de nuevos derivados de oxabicicloalcano. | |
ES517222A0 (es) | Un procedimiento para la preparacion de derivados de acilmorrfinano. | |
ES512880A0 (es) | Un procedimiento para la preparacion de derivados de 4-anilino-pirimidina. | |
ES514264A0 (es) | Un procedimiento para la preparacion de derivados de tiazolidi-nilalquilen-piperazinas. | |
ES509437A0 (es) | Un procedimiento para la preparacion de derivados carbapenen-2-tio-sustituidos. | |
ES516825A0 (es) | Un procedimiento para la preparacion de nuevos derivados de 3-amino-pregn-5-eno. | |
ES513880A0 (es) | Un procedimiento para la preparacion de derivados de triazolurea. | |
ES510067A0 (es) | Un procedimiento para la preparacion de nuevos derivados de benzoilurea. | |
ES521471A0 (es) | Un procedimiento para la preparacion de un derivado de carbostirilo. | |
ES515655A0 (es) | Un procedimiento para la preparacion de derivados de benzotiazolina. | |
ES511224A0 (es) | Un procedimiento para la preparacion de nuevos derivados de 2-piperazino pirimioina. | |
ES510611A0 (es) | Un procedimiento para la preparacion de derivados de desoxiuridina. | |
ES513967A0 (es) | Un procedimiento para la preparacion de derivados de etanola-mina. | |
ES518296A0 (es) | Un procedimiento para la preparacion de un derivado de piridoindol. | |
ES514263A0 (es) | Un procedimiento para la preparacion de derivados de espiroti-azolidinil-piperazina. | |
ES514213A0 (es) | Un procedimiento para la preparacion de nuevos derivados poliprenilicos. | |
ES508775A0 (es) | Un procedimiento para la preparacion de derivados de ciclo- hepteno. | |
ES517852A0 (es) | Un procedimiento para la preparacion de derivados de bencenosulfonamidas. | |
ES521021A0 (es) | Un procedimiento para la preparacion de nuevos derivados de fosfolipidos. | |
ES514864A0 (es) | Un procedimiento para la preparacion de derivados de trifluormetanosulfonanilida. | |
ES514486A0 (es) | Un procedimiento para la preparacion de derivados de aminonaftaceno. | |
ES512463A0 (es) | Un procedimiento para la preparacion de un derivado de beta-lactama. | |
ES515365A0 (es) | Un procedimiento para la preparacion de un derivado de furanocremona. | |
ES520820A0 (es) | Un procedimiento para la preparacion de derivados de pirrolidina. |